What is DirectMeds?

DirectMeds is a telehealth platform focused on medically supervised weight loss, offering physician-prescribed access to compounded GLP-1 medications — specifically semaglutide and tirzepatide — at dramatically lower prices than brand-name alternatives.

The platform sits in a crowded space, but distinguishes itself through genuine pricing transparency, a straightforward clinical process, and strong nationwide availability. It's the platform we recommend most often to people who simply want effective, affordable, clinician-supervised GLP-1 access without navigating a complicated system.

On compounded GLP-1 medications: DirectMeds prescribes compounded semaglutide and tirzepatide — medications containing the same active ingredients as brand-name GLP-1 drugs but prepared by licensed compounding pharmacies. Compounded versions are legal when prescribed by a licensed physician and are available at significantly lower monthly costs than brand-name alternatives.

How DirectMeds works

Pricing — what DirectMeds actually costs

This is where DirectMeds earns its top rating. Pricing is straightforward and disclosed clearly before you commit:

Compare this to higher-cost brand-name alternatives and it becomes clear why compounded GLP-1 telehealth has become the dominant access route for most patients in 2026. DirectMeds sits at the more affordable end of the compounded telehealth market without compromising on clinical quality.

DirectMeds does not accept insurance. HSA/FSA funds may apply depending on your plan.

Clinical quality — how does the medical oversight actually hold up?

Our most important evaluation criterion is always clinical quality — because a platform that makes GLP-1 medications easy to get without appropriate medical oversight is dangerous, not helpful.

DirectMeds passes this test. Every prescription decision involves a licensed physician review of your health history and current medications. The titration schedules prescribed are consistent with clinical best practices — starting low and increasing gradually to minimize gastrointestinal side effects. And the ongoing monitoring relationship gives patients a clinical contact point if issues arise.

What we look for and what DirectMeds delivers: real physician involvement at every prescription decision, screening for contraindications (history of thyroid cancer, pancreatitis, pregnancy), appropriate starting doses, and ongoing access to clinical support. All of those boxes are checked.

How DirectMeds compares to other GLP-1 platforms

FeatureDirectMedsZealthyTrimiAM Rx
Compounded semaglutide✓ Yes✓ Yes✓ Yes✓ Yes
Compounded tirzepatide✓ Yes✓ Yes✓ YesLimited
Starting price~$99/mo~$149/mo~$99/mo~$129/mo
Physician consultation included✓ Yes✓ Yes✓ Yes✓ Yes
All 50 states✓ Yes✓ YesMost states✓ Yes
Ongoing monitoring✓ Yes✓ Yes✓ YesLimited

Who DirectMeds is right for

DirectMeds is an excellent fit for most adults seriously considering GLP-1 therapy:

DirectMeds is a less ideal fit if you need specialized hormonal support (see FemExcel for women or Rugiet for men), or if you're specifically interested in longevity interventions beyond weight loss (see AgelessRx).

Side effects — what to expect

GLP-1 medications have a well-documented side effect profile. The most common are gastrointestinal: nausea, vomiting, diarrhea, and constipation — particularly in the early weeks as your dose is being established. These typically improve as your body adjusts and as your dose is titrated gradually.

Less common but more serious side effects include pancreatitis, gallbladder disease, and (very rarely) thyroid tumors. These are screened for during intake. Your DirectMeds physician will discuss the full risk-benefit profile with you before prescribing.

The gradual titration schedule that DirectMeds uses — starting at a low dose and increasing over several months — is specifically designed to minimize GI side effects and is consistent with how obesity medicine specialists approach GLP-1 prescribing.

Check your eligibility at DirectMeds

The eligibility check is free and takes under 10 minutes. A licensed physician reviews every application — no automated approvals. Compounded semaglutide starts at approximately $99/month.

Check your DirectMeds eligibility →

Frequently asked questions

Is DirectMeds legitimate?
Yes. DirectMeds is a legitimate telehealth platform operating legally in all 50 states. All prescriptions are issued by licensed physicians and filled by licensed compounding pharmacies. As with any telehealth service, it is not a substitute for in-person care when that is clinically warranted.
How is compounded semaglutide different from brand-name semaglutide?
Both contain semaglutide as the active ingredient and work through the same biological mechanism. Brand-name semaglutide goes through the manufacturer's full drug approval process. Compounded semaglutide is prepared by a licensed compounding pharmacy — legal when prescribed by a licensed physician. The clinical mechanism is the same; compounded versions are available at significantly lower monthly costs.
How quickly will I lose weight on GLP-1 medication?
Most patients notice reduced appetite within 2–4 weeks. Meaningful weight loss typically becomes visible over 8–16 weeks as doses are titrated upward. Clinical trials show average weight loss of 15–25% of body weight over 12–18 months in appropriate candidates. Individual results vary based on dosage, diet, activity level, and individual physiology.
What happens if I want to stop?
You can cancel your DirectMeds program at any time. Note that most research shows weight regain occurs after stopping GLP-1 therapy — this is an important factor to discuss with your provider when planning your long-term approach. Stopping is straightforward and does not require a formal medical taper.

Our verdict

DirectMeds earns its position as our top-rated GLP-1 telehealth platform for 2026. The combination of genuine pricing transparency, real physician oversight, strong nationwide availability, and access to both semaglutide and tirzepatide makes it the default recommendation for most people researching compounded GLP-1 therapy.

It's not the only good option — see our full 2026 rankings for a complete comparison — but for straightforward GLP-1 access with solid clinical standards, DirectMeds is where we'd start.

Rating: 4.8/5  ·  Editor's Pick for 2026

Check your DirectMeds eligibility → Free eligibility check  ·  Physician review required  ·  Prescription medications carry risks